Interleukin-18 modulation in autism spectrum disorders

Journal of Neuroinflammation

Volumn 13, Issue 1, 2016, Pages

  Businaro, Rita ^a   Corsi, Mariangela ^a   Azzara, Gabriella ^a   Di Raimo, Tania ^a   Laviola, Giovanni ^b   Romano, Emilia ^b   Ricci, Lidia ^a   Maccarrone, Mauro ^c,d   Aronica, Eleonora ^e   Fuso, Andrea ^a,c   Ricci, Serafino ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Autism; Cytokines; ELISA; IL 18; Immunohistochemistry; Reeler mice

Indexed keywords

INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; INTERLEUKIN-18 BINDING PROTEIN; SIGNAL PEPTIDE;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING; WILD TYPE; ANIMAL; BRAIN; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PRESCHOOL CHILD; QUESTIONNAIRE; TRANSGENIC MOUSE; YOUNG ADULT;

ADOLESCENT; ANIMALS; AUTISM SPECTRUM DISORDER; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHILD; CHILD, PRESCHOOL; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; MALE; MICE; MICE, NEUROLOGIC MUTANTS; MICE, TRANSGENIC; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84952837227     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/s12974-015-0466-6     Document Type: Article

References (53)

1. Ratacczak HV. Theoretical aspects of autism: causes-a review. J Immunotoxicol. 2011;8:68-79. doi: 10.1192/bjp.bp.108.059345.
2. Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE, et al. Prevalence of autism spectrum conditions: UK school-based population study. Br J Psychiatry. 2009;194:500-9. doi: 10.1192/bjp.bp.108.059345.
3. Mitchell RH, Goldstein BI. Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J Am Acad Child Adolesc Psychiatry. 2014;53:274-96. doi: 10.1016/j.jaac.2013.11.013.
4. Noriega DB, Savelkoul HF. Immune dysregulation in autism spectrum disorder. Eur J Pediatr. 2014;173:33-43. doi: 10.1007/s00431-013-2183-4.
5. Garay PA, McAllister AK. Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders. Front SynapticNeurosci. 2010;8(2):136. doi: 10.3389/fnsyn.2010.00136.
6. Takano T. Role of microglia in autism: recent advances. Dev Neurosci. 2015;37:195-202. doi: 10.1159/000398791.
7. Estes ML, McAllister AK. Immune mediators in the brain and peripheral tissues in autism spectrum disorder. Nat Rev Neurosci. 2015;16:469-86. doi: 10.1038/nrn3978.
8. Ye L, Huang Y, Zhao L, Li Y, Sun L, Zhou Y, et al. IL-1β and TNF-aα induce neurotoxicity through glutamate production: a potential role for neuronal glutaminase. J Neurochem. 2013;125:897-908. doi: 10.1111/jnc.12263.
9. Ricci S, Businaro R, Ippoliti F, Lo Vasco VR, Massoni F, Onofri E, et al. Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res. 2013;24:491-501. doi: 10.1007/s12640-013-9393-4.
10. Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002;25:154-9.
11. Ricci S, Fuso A, Ippoliti F, Businaro R. Stress-induced cytokines and neuronal dysfunction in Alzheimer's disease. J Alzheimers Dis. 2012;28:11-24. doi: 10.3233/JAD-2011-110821.
12. Depino AM. Peripheral and central inflammation in autism spectrum disorders. Mol Cell Neurosci. 2013;53:69-76. doi: 10.1016/j.mcn.2012.10.003.
13. Alboni S, Cervia D, Sugama S, Conti B. Interleukin 18 in the CNS. J Neuroinflammation. 2010;7:9. doi: 10.1186/1742-2094-7-9.
14. Novick D, Kim S, Kaplanski G, Dinarello CA. Interleukin-18, more than a Th1 cytokine. Semin Immunol. 2013;25:439-48. doi: 10.1016/j.smim.2013.10.014.
15. Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4:289. doi: 10.3389/fimmu.2013.00289.
16. Ojala J, Alafuzoff I, Herukka SK, van Groen T, Tanila H, Pirttilä T. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol Aging. 2009;30:198-209. doi: 10.1016/j.neurobiolaging.2007.06.006.
17. Sutinen EM, Pirttilä T, Anderson G, Salminen A, Ojala JO. Pro-inflammatory interleukin-18 increases Alzheimer's disease-associated amyloid-β production in human neuron-like cells. J Neuroinflammation. 2012;9:199. doi: 10.1186/1742-2094-9-199.
18. Sutinen EM, Korolainen MA, Häyrinen J, Alafuzoff I, Petratos S, Salminen A, et al. Interleukin-18 alters protein expressions of neurodegenerative diseases-linked proteins in human SH-SY5Y neuron-like cells. Front Cell Neurosci. 2014;8:214. doi: 10.3389/fncel.2014.00214.
19. Fatemi SH, Folsom TD, Kneeland RE, Yousefi MK, Liesch SB, Thuras PD. Impairment of fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling and its downstream cognates ras-related C3 botulinum toxin substrate 1, amyloid beta A4 precursor protein, striatal-enriched proteintyrosine phosphatase, and homer 1, in autism: a postmortem study in cerebellar vermis and superior frontal cortex. Mol Autism. 2013;4:21. doi: 10.1186/2040-2392-4-21.
20. Laviola G, Adriani W, Gaudino C, Marino R, Keller F. Paradoxical effects of prenatal acetylcholinesterase blockade on neuro-behavioral development and drug-induced stereotypies in reeler mutant mice. Psychopharmacology (Berl). 2006;187:331-44. doi: 10.1007/s00213-006-0426-z.
21. Prabowo AS, Iyer AM, Veersema TJ, Anink JJ, Schouten-van Meeteren AY, Spliet WG, et al. BRAF V600E mutation is associated with mTOR signaling activation in glioneuronal tumors. Brain Pathol. 2014;24:52-66. doi: 10.1111/bpa.12081.
22. Andersen TE, Finsen B, Goffinet AM, Issinger OG, Boldyreff B. A reeler mutant mouse with a new, spontaneous mutation in the reelin gene. Brain Res Mol Brain Res. 2002;105:153-6. doi: 10.1016/S0169-328X(02)00389-3.
23. Keller F, Persico AM. The neurobiological context of autism. Mol Neurobiol. 2003;28:1-22. doi: 10.1385/MN:28:1:1.
24. Goines PE, Ashwood P. Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment. Neurotoxicol Teratol. 2013;36:67-81. doi: 10.1016/j.ntt.2012.07.006.
25. State MW, Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders. Nat Neurosci. 2011;14:1499-506. doi: 10.1016/j.ntt.2012.07.006.
26. Voineagu I, Eapen V. Converging pathways in autism spectrum disorders: interplay between synaptic dysfunction and immune responses. Front Hum Neurosci. 2013;7:738. doi: 10.3389/fnhum.2013.00738.
27. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333(6048):1456-8. doi: 10.1126/science.1202529.
28. Onore C, Careaga M, Ashwood P. The role of immune dysfunction in the pathophysiology of autism. Brain Behav Immun. 2012;26:383-92. doi: 10.1016/j.bbi.2011.08.007.
29. Mead J, Ashwood P. Evidence supporting an altered immune response in ASD. Immunol Lett. 2015;163:49-55. doi: 10.1016/j.imlet.2014.11.006.
30. Motta M, Imbesi R, Di Rosa M, Stivala F, Malaguarnera L. Altered plasma cytokine levels in Alzheimer's disease: correlation with the disease progression. Immunol Lett. 2007;114:46-51. doi: 10.1016/j.imlet.2007.09.002.
31. Al-Ayadhi LY, Ben Bacha AG, Kotb M, El-Ansary AK. A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics. Behav Brain Funct. 2012;8:4. doi: 10.1186/1744-9081-8-4.
32. El-Ansary AK, Ben Bacha AG, Al-Ayadhi LY. Proinflammatory and proapoptotic markers in relation to mono and di-cations in plasma of autistic patients from Saudi Arabia. J Neuroinflammation. 2011;8:142. doi: 10.1186/1742-2094-8-142.
33. Li X, Chauhan A, Sheikh AM, Patil S, Chauhan V, Li XM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol. 2009;207:111-6. doi: 10.1016/j.jneuroim.2008.12.002.
34. Alboni S, Cervia D, Ross B, Montanari C, Gonzalez AS, Sanchez-Alavez M, et al. Mapping of the full length and the truncated interleukin-18 receptor alpha in the mouse brain. J Neuroimmunol. 2009;214:43-54. doi: 10.1016/j.jneuroim.2009.06.016.
35. Andre R, Wheeler RD, Collins PD, Luheshi GN, Pickering-Brown S, Kimber I, et al. Identification of a truncated IL-18R beta mRNA: a putative regulator of IL-18 expressed in rat brain. J Neuroimmunol. 2003;145:40-5. http://dx.doi.org/10.1016/j.jneuroim.2003.09.005
36. Sugama S, Conti B. Interleukin-18 and stress. Brain Res Rev. 2008;58:85-95. doi: 10.1016/j.brainresrev.2007.11.003.
37. Fiszer D, Rozwadowska N, Rychlewski L, Kosicki W, Kurpisz M. Identification of IL-18RAP mRNA truncated splice variants in human testis and the other human tissues. Cytokine. 2007;39:178-83. doi: 10.1016/j.cyto.2007.07.186.
38. Ojala JO, Sutinen EM, Salminen A, Pirttilä T. Interleukin-18 increases expression of kinases involved in tau phosphorylation in SH-SY5Y neuroblastoma cells. J Neuroimmunol. 2008;205:86-93. doi: 10.1016/j.jneuroim.2008.09.012.
39. Yaguchi T, Nagata T, Yang D, Nishizaki T. Interleukin-18 regulates motor activity, anxiety and spatial learning without affecting synaptic plasticity. Behav Brain Res. 2010;206:47-51. doi: 10.1016/j.bbr.2009.08.033.
40. Miyoshi K, Obata K, Kondo T, Okamura H, Noguchi K. Interleukin-18-mediated microglia/astrocyte interaction in the spinal cord enhances neuropathic pain processing after nerve injury. J Neurosci. 2008;28:12775-87. doi: 10.1523/JNEUROSCI.3512-08.2008.
41. Losy J, Niezgoda A. IL-18 in patients with multiple sclerosis. Acta Neurol Scand. 2001;104:171-3. doi: 10.1034/j.1600-0404.2001.00356.x.
42. Oztürk C, Ozge A, Yalin OO, Yilmaz IA, Delialioglu N, Yildiz C, et al. The diagnostic role of serum inflammatory and soluble proteins on dementia subtypes: correlation with cognitive and functional decline. Behav Neurol. 2007;18:207-15.
43. Cumiskey D, Curran BP, Herron CE, O'Connor JJ. A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus. Neuropharmacology. 2007;52:1616-23. doi: 10.1016/j.neuropharm.2007.03.006.
44. Heo Y, Zhang Y, Gao D, Miller VM, Lawrence DA. Aberrant immune responses in a mouse with behavioral disorders. PLoS One. 2011;6:e20912. doi: 10.1371/journal.pone.0020912.
45. Okamura H, Tsutsi H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378:88-91. doi: 10.1038/378088a0.
46. Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL, et al. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 2003;48:339-47. doi: 10.1002/art.10814.
47. Leonard BE. HPA and immune axes in stress: involvement of the serotonergic system. Neuroimmunomodulation. 2006;13:268-76. doi: 10.1159/000104854.
48. Leonard BE. The concept of depression as a dysfunction of the immune system. Curr Immunol Rev. 2010;6:205-12. doi: 10.2174/157339510791823835.
49. Anderson G, Ojala J. Alzheimer's and seizures: interleukin-18, indoleamine 2,3-dioxygenase and quinolinic Acid. Int J Tryptophan Res. 2010;3:169-73. doi: 10.4137/IJTR.S4603.
50. Chugani DC, Muzik O, Rothermel R, Behen M, Chakraborty P, Mangner T, et al. Altered serotonin synthesis in the dentatothalamcortical pathway in autistic boys. Ann Neurol. 1997;42:666-9.
51. Mostafa GA, Al-Ayadhi LY. A lack of association between hyperserotonemia and the increased frequency of serum anti-myelin basic protein auto-antibodies in autistic children. J Neuroinflammation. 2011;8:71. doi: 10.1186/1742-2094-8-71.
52. Chugani DC. Serotonin in autism and pediatric epilepsies. Ment Retard Dev Disabil Res Rev. 2004;10:112-6.
53. Jeon GS, Park SK, Park SW, Kim DW, Chung CK, Cho SS. Glial expression of interleukin-18 and its receptor after excitotoxic damage in the mouse hippocampus. Neurochem Res. 2008;33:179-84. doi: 10.1007/s11064-007-9434-6.